Editorial orientation provided by MedAPI — not part of the coding instruction.
C09 describes primary malignant neoplasms of the tonsil, principally the palatine tonsil and adjacent tonsillar fossa or pillars. These tumors are clinically managed as oropharyngeal cancers.
Common Histologies
- Squamous cell carcinoma is by far the most common histology.
- Many tonsillar squamous cell carcinomas are human papillomavirus (HPV)-mediated, typically associated with high-risk HPV.
- Less common epithelial tumors include salivary-type carcinomas arising from minor salivary glands.
- Lymphomas involving the tonsil are classified in the appropriate lymphoma family rather than by C09.
Common Symptoms
- Persistent unilateral sore throat or tonsillar enlargement (R07.0)
- Neck mass from cervical lymph-node involvement, sometimes as the first presentation (C77.0)
- Painful or difficult swallowing (R13.10)
- Referred ear pain (H92.09)
- Muffled voice (R49.8), oral bleeding (R04.1), or trismus in more advanced disease (M26.52)
- Constitutional symptoms or weight loss in advanced cases (R63.4)
Diagnosis
Evaluation generally includes careful oral and oropharyngeal examination, flexible endoscopy, and biopsy for histologic confirmation. Contrast-enhanced CT or MRI assesses the primary tumor and cervical nodes; FDG PET/CT may be used for staging or evaluation of an unknown primary presenting with nodal disease. Dental, nutritional, swallowing, and airway assessments may be relevant before treatment.
Staging
Tonsillar cancers are staged as oropharyngeal malignancies using tumor extent, regional lymph-node involvement, and distant metastasis. HPV-mediated, p16-positive oropharyngeal squamous cell carcinoma has a distinct staging framework from p16-negative disease. Cervical nodal metastases are common, including cystic nodal disease in HPV-associated tumors.
Molecular Markers
For tonsillar squamous cell carcinoma, p16 immunohistochemistry is commonly used as a surrogate marker for HPV-mediated disease. HPV-specific testing may be performed when clinically indicated. HPV status has important prognostic and staging implications but does not by itself determine the C09 site code.
Common Treatments
Treatment depends on stage, resectability, HPV status, functional considerations, and patient factors. Options include:
- Transoral surgical resection with appropriate neck management
- Definitive radiation therapy for selected localized disease
- Concurrent chemoradiation for many locally advanced tumors
- Systemic therapy, immunotherapy, radiation, or selected salvage surgery for recurrent or metastatic disease
Multidisciplinary management is important because treatment may affect swallowing, speech, nutrition, dental health, and long-term airway function.
Scope Note
C09 identifies the primary anatomic site within the tonsil, including the tonsillar fossa, tonsillar pillars, overlapping tonsillar sites, or an unspecified tonsillar site. It does not encode histology, HPV or p16 status, grade, stage, nodal involvement, distant metastasis, or treatment status. C09 does not include malignant neoplasm of the lingual tonsil, classified to C02.4, or the pharyngeal tonsil, classified to C11.1. Secondary involvement of the tonsil by metastatic disease should not be represented as a primary C09 malignancy; metastatic sites and associated exposures or substance-use conditions are coded separately when applicable.